Neuraxpharm and mjn-neuro to Launch AI Wearable for Early Seizure Detection

November 27, 2025
Neuraxpharm and mjn-neuro announced plans to launch EPISERAS, an AI-powered wearable device designed to predict epileptic seizures in real time. The certified medical device uses a discreet earpiece sensor to monitor brain activity and alert users minutes before a potential seizure.

Neuraxpharm and mjn-neuro announced in a press release plans to launch EPISERAS, a digital health solution that uses artificial intelligence to predict the risk of epileptic seizures in real time.

EPISERAS is a non-invasive medical device that continuously records brain activity through a discreet earpiece sensor. The system analyses electrical patterns in the brain using AI algorithms to identify when a seizure is likely to occur and sends alerts minutes in advance when the risk is high.

The device connects to a mobile application that displays seizure-risk data and notifications for patients and caregivers. It is designed for individuals with drug-resistant epilepsy, providing a proactive monitoring tool to improve safety in daily life.

EPISERAS has received CE and UKCA certification as a Class IIa medical device in Europe. A multicentre clinical study, SERAS-Home_RWD, is currently being conducted across Spain, the UK, and Germany to further validate the technology.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

11/27
DataM Intelligence Projects In-Silico Clinical Trials Market to Reach $6.39 Billion by 2033
11/27
AdvaHealth Solutions Introduces Cloud-Native AdvaPACS Imaging Platform
11/26
Keyin College, Huron, and Vantiq Partner with NL Health Services on Digital Health Innovation
11/24
Sectra Showcases AI-Integrated Imaging Platform at RSNA 2025
11/21
Greenway Health Unveils Automated Healthcare Practice at ENGAGE 2025

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like